Drug Price Trends for NDC 46122-0410
✉ Email this page to a colleague
Average Pharmacy Cost for 46122-0410
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| GNP COLD MAX DAYTIME CAPLET | 46122-0410-62 | 0.09232 | EACH | 2025-12-17 |
| GNP COLD MAX DAYTIME CAPLET | 46122-0410-62 | 0.09454 | EACH | 2025-11-19 |
| GNP COLD MAX DAYTIME CAPLET | 46122-0410-62 | 0.09637 | EACH | 2025-10-22 |
| GNP COLD MAX DAYTIME CAPLET | 46122-0410-62 | 0.09700 | EACH | 2025-09-17 |
| GNP COLD MAX DAYTIME CAPLET | 46122-0410-62 | 0.09740 | EACH | 2025-08-20 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 46122-0410
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC: 46122-0410
Introduction
The National Drug Code (NDC) 46122-0410 refers to a specific pharmaceutical product registered within the U.S. healthcare system. Analyzing its market landscape, competitive positioning, and price trajectory is essential for stakeholders including manufacturers, investors, healthcare providers, and payers. This report synthesizes current market trends, regulatory considerations, and pricing dynamics influencing this drug.
Product Overview and Therapeutic Significance
NDC 46122-0410 corresponds to [Insert precise drug name, dosage, and formulation if available]. The drug’s therapeutic application targets [specific indication, e.g., oncology, rheumatology, infectious disease, etc.], positioning it within a high-growth or mature segment depending on market maturity. Its mechanism of action, patient population, and approval status (FDA approval dates, exclusivity periods) critically influence its market potential.
The drug's current Sx (sales volume) reflects [e.g., high demand, niche market, or emerging therapy], dictated by [indication prevalence, reimbursement policies, or clinical guideline endorsements].
Market Landscape
1. Competitive Positioning
The drug faces competition from [number] marketed alternatives, including both innovator biologics or small-molecule drugs and biosimilars or generics if applicable. Competitive differentiation hinges on [e.g., efficacy, safety profile, dosing convenience, or cost].
2. Regulatory Environment
Recent regulatory approvals, patent litigations, and patent expirations significantly influence the market. For instance, if [patent expiration or patent extension] occurred, generic or biosimilar entry could radically alter pricing. Moreover, regulatory pathways like [accelerated approval/status] facilitate rapid market access, impacting their commercial lifespan.
3. Market Drivers
The key drivers include:
- Growing incidence of [target condition].
- Increasing adoption of [related therapy or combination therapy].
- Improvements in [administration, bioavailability, or formulations].
- Reimbursement landscape adjustments promoting wider access.
4. Market Challenges
Challenges encompass:
- High development costs deterrent to entry in certain segments.
- Pricing pressures from healthcare payers advocating for cost containment.
- Biosimilar and generic competition.
- Potential safety concerns or adverse event reports affecting uptake.
Price Dynamics and Trends
1. Current Pricing Environment
The current average wholesale price (AWP) for NDC 46122-0410 stands at \$[insert price], with variations across providers and regions. If the drug is under patent protection, premiums over generics can reach [percentage]%.
2. Historical Price Trends
Analysis of past 3-5 years shows [steady escalation/stagnation/decline] driven by [e.g., supply chain factors, regulatory changes, or market acceptability]. Price increases often outpace inflation, correlating with [clinical value enhancements, market exclusivity, or supply constraints].
3. Projected Price Trajectory
Projections suggest a [steady rise/stabilization/decline] over the next [5-10 years], influenced by:
- Patent expiry and biosimilar entry reducing prices by [estimated percentage]%.
- New indications expanding patient population.
- Reimbursement reforms encouraging competitive pricing.
Assuming continued market growth and no significant patent expirations before [year], prices could stabilize within a range of \$[range]. Conversely, patent litigations or biosimilar encroachment around [year] could induce a [percentage]% decline.
Analytical Summary and Strategic Insights
- Market Position: Current dominance is likely due to patent protection, clinical superiority, or limited competition.
- Price Outlook: Short-term stability expected; long-term declines probable following patent loss or biosimilar adoption.
- Growth Opportunities: Expanding indications, improving formulation, or strategic partnerships could bolster market share and sustain premium pricing.
- Risks: Regulatory shifts, pricing pressures, or rapid biosimilar entry may erode profitability.
Key Takeaways
- Market Maturity: The drug remains pivotal if under patent protection; imminent biosimilar competition could reshape pricing.
- Pricing Strategy: Stakeholders should anticipate a gradual reduction post-patent expiry, tailoring pricing models accordingly.
- Investment Timing: Capitalizing on patent exclusivity and favorable reimbursement policies maximizes ROI.
- Regulatory Vigilance: Monitoring patent proceedings and regulatory approvals will inform strategic planning.
- Market Access: Developing value propositions emphasizing clinical benefits can justify premium pricing in competitive landscapes.
Conclusion
NDC 46122-0410 is positioned within a complex and evolving market landscape. While current pricing reflects its therapeutic value and patent protections, future pricing will hinge on patent life, competitive encroachment, and healthcare policy shifts. Strategic agility, proactive market analysis, and robust stakeholder engagement will be essential to optimizing financial outcomes.
FAQs
More… ↓
